Protective effect of tiopronin supplemented with chemotherapy in treating advanced breast cancer
- VernacularTitle:硫普罗宁联合化疗治疗晚期乳腺癌的临床观察
- Author:
Huanwei CHEN
;
Xiaoqiong ZHAO
;
Xianming FENG
;
Huahai LIN
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Antneoplastic combined chemotherapy protocols;
Tiopronin
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(11):1825-1826
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the efficacy and safety of tiopronin supplemented with chemotherapy in treating advanced breast cancer.Methods Sixty patients with advanced breast cancer were randomly divided into two groups:treatment group(n = 28) and control group (n = 32).Two groups were treated the same of NVB + DDP,the treatment group was supplemented with tiopronin,given for 10 days.Efficacy,toxicity in two groups were compared.Results The effective rate in the treatment group and the control group were 46.4% and 46.9% respectively, with no significant difference between the two groups ,P > 0.05.But the improved quality of life of patients in the treatment group was higher than that in the control group, P < 0.05.The rate of adverse reaction in liver function damaged (9.4%)and leucocyte lassitude(46.4%) were apparent lower than those in the control group(31.2% ,81.2% ),with significant difference between the two groups(P < 0.05, P < 0.01).Conclusion Tiopronin supplemented with chemotherapy show apparent effect in decreasing the adverse reaction of chemotherapy,improving the quality of life and not influence efficacy in advanced breast cancer.So tiopronln may act as protective drug for chemotherapy and deserve further testing in the clinic.
